| Ytd | 58.81% | |
| 1y | 47.09% |
| Open | 1.49 | Prev Close | 1.47 | Low | 1.46 | High | 1.52 | Mkt Cap | 174.64M |
| Vol | 427.69K | Avg Vol | 620.55K | EPS | -0.28 | P/E | -5.39 | Forward P/E | -4.03 |
| Beta | 0.72 | Short Ratio | 1.37 | Inst. Own | 9.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.14 | 200-d Avg | 1.13 | 1yr Est | 8.70 |
CRDL News
Cardiol Therapeutics (NASDAQ: CRDL - Get Free Report) is expected to post its Q2 2026 results after
TORONTO, Aug. 5, 2026 /PRNewswire/ -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol
HC Wainwright & Co. analyst Brandon Folkes reiterates Cardiol Therapeutics (NASDAQ:CRDL) with
The publication comes as the pivotal Phase III MAVERIC trial nears full patient enrollment. The publ
• Peer-reviewed JAHA publication strengthens the foundation for Cardiol's pivotal Phase III MAVERIC
TORONTO, July 9, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol"
TORONTO, June 25, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol
TORONTO, June 23, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol
TORONTO, May 14, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol"
Results demonstrate CardiolRx™ may represent a paradigm shift in the treatment of patients with recu
Leading enrolling centers include Cleveland Clinic, three major campuses of the Mayo Clinic, Northwe
Corcept Therapeutics (NASDAQ: CORT - Get Free Report) and Cardiol Therapeutics (NASDAQ: CRDL - Get F
Toronto, Ontario--(Newsfile Corp. - April 14, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX:
Initiated pivotal Phase III MAVERIC trial of CardiolRx™ in recurrent pericarditis and surpassed 50%
Cardiol Therapeutics (NASDAQ: CRDL) used a presentation at TD Cowen's 46th Annual Healthcare Confere
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (T
Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (T
Cardiol Therapeutics Inc. (TSE: CRDL - Get Free Report) shares fell 7.1% during mid-day trading on T
Cardiol Therapeutics Inc. (TSE: CRDL - Get Free Report) shares fell 7.1% during trading on Thursday.
Toronto, Ontario--(Newsfile Corp. - January 23, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TS
Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TS
Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TS
On Friday morning, 446 companies hit new 52-week lows.
During Tuesday's session, 78 companies made new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
During Monday's trading, 528 companies set new 52-week lows.
On Friday, 404 stocks made new 52-week lows.
On Tuesday, 44 companies hit new 52-week lows.
During Monday's session, 402 companies made new 52-week lows.
During Friday's session, 198 companies made new 52-week lows.
During Tuesday's trading, 505 companies set new 52-week lows.